FTC Notices of Penalty Offenses Concerning Claim Substantiation Issued to Almost 700 Health Product Companies
On April 13, 2023, the Federal Trade Commission (“FTC”) sent Notices of Penalty Offenses Concerning Substantiation of Product Claims (“Substantiation Notice”) and Deceptive or Unfair Conduct around Endorsements and Testimonials (“Endorsement Notice”) (collectively “Notices”) to about 670 companies that market OTC drugs, homeopathic products, dietary supplements, and/or functional foods and that made claims about the efficacy or […]